期刊
CLINICAL INFECTIOUS DISEASES
卷 50, 期 7, 页码 E47-E49出版社
OXFORD UNIV PRESS INC
DOI: 10.1086/651166
关键词
-
资金
- Department of Clinical Pharmacy, University of California, San Francisco, California
- South East Asian Influenza Clinical Research Network
- US National Institute of Allergy and Infectious Diseases [N01-AO-00042]
- Wellcome Trust of Great Britain [077166/Z/05/Z]
The safety of high-dose oseltamivir during treatment of 2009 H1N1 influenza A infection for critically ill patients is unknown. Here we report on a case patient with severe, delayed-onset neuropsychiatric symptoms after administration of high-dose oseltamivir. Clinicians should be vigilant to the possible increased risk of complications associated with high-dose oseltamivir therapy for 2009 H1N1 influenza A infection.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据